Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation

Andreas G. Tzakis*, Panagiotis Tryphonopoulos, Tomoaki Kato, Seigo Nishida, David M. Levi, Juan R. Madariaga, Jeffrey J. Gaynor, Werviston De Faria, Arie Regev, Violet Esquenazi, Debbie Weppler, Phillip Ruiz, Joshua Miller

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Fingerprint Dive into the research topics of 'Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences